93 related articles for article (PubMed ID: 6804088)
1. Pharmaceutics: mitomycin C: a brief review.
Reich SD
Cancer Nurs; 1982 Apr; 5(2):152-4. PubMed ID: 6804088
[No Abstract] [Full Text] [Related]
2. [Clinical study of 47 patients with stomach cancer treated with mitomycin C].
Paolucci R
Cancro; 1971; 24(3):153-9. PubMed ID: 4949673
[No Abstract] [Full Text] [Related]
3. Mitomycin (Mutamycin).
Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
[No Abstract] [Full Text] [Related]
4. [Analysis of factors affecting clinical cancer chemotherapy].
Wakui A; Taguchi T
Gan No Rinsho; 1983 Aug; 29(10):1199-204. PubMed ID: 6415312
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with mitomycin C (NSC-26980).
Whittington RM; Close HP
Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
[No Abstract] [Full Text] [Related]
6. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
7. [Combined administration of mitomycin C for the improved management of stomach neoplasms].
Kakuta H; Kikuchi A; Nagano S; Machida S; Fukushima M; Ishikawa Y
Nihon Rinsho; 1978 Jun; 36(6):2576-80. PubMed ID: 359865
[No Abstract] [Full Text] [Related]
8. The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
Kelsen D
Semin Oncol; 1994 Aug; 21(4 Suppl 7):58-66. PubMed ID: 8091242
[TBL] [Abstract][Full Text] [Related]
9. [Administration of mitomycin-C with an inactivator].
Takahashi M; Yoshida K
Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):525-7. PubMed ID: 3932560
[No Abstract] [Full Text] [Related]
10. [Effect of intratumor mitomycin-C injection on growth of homologously implanted pancreatic cancer in Syrian golden hamster].
Moriai T; Takebe T; Ohyama K
Nihon Shokakibyo Gakkai Zasshi; 1986 Aug; 83(8):1515-9. PubMed ID: 3097356
[No Abstract] [Full Text] [Related]
11. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C: experience in the United States, with emphasis on gastric cancer.
Schein PS; Macdonald JS; Hoth D; Wooley PV
Cancer Chemother Pharmacol; 1978; 1(2):73-5. PubMed ID: 750107
[No Abstract] [Full Text] [Related]
13. [Chemotherapy of stomach cancer-with special reference to massive and intermittent administration of mitomycin C].
Matsunaga F; Shimoyama T; Mikawa K; Ishiwata J; Kikuchi H
Naika; 1966 Jun; 17(6):1101-15. PubMed ID: 5964528
[No Abstract] [Full Text] [Related]
14. [Administration of large doses of mitomycin C during stomach cancer surgery. Postoperative survival rates following palliative resection].
Hattori T; Ito I; Hirata K; Iizuka T; Abe K
Gan No Rinsho; 1965 Nov; 11(12):817-26. PubMed ID: 5894619
[No Abstract] [Full Text] [Related]
15. [Intratumoral injection of mitomycin for adenocarcinoma of the duodenum].
Wagner A; Waitz W
Dtsch Med Wochenschr; 1990 May; 115(19):757. PubMed ID: 2110879
[No Abstract] [Full Text] [Related]
16. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
[TBL] [Abstract][Full Text] [Related]
17. Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence.
Imanaga H; Nakazato H
World J Surg; 1977 Mar; 2(1):213-21. PubMed ID: 868069
[No Abstract] [Full Text] [Related]
18. Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation.
Chalasani P; Kurtin S; Dragovich T
JOP; 2008 May; 9(3):305-8. PubMed ID: 18469443
[TBL] [Abstract][Full Text] [Related]
19. [Case of unresectable gastric cancer for wich splenectomy was performed because massive administration of mitomycin C did not reduce the number of leukocytes].
Ono K; Shimano M
Gan No Rinsho; 1968 Oct; 14(10):874-8. PubMed ID: 5750972
[No Abstract] [Full Text] [Related]
20. [Isolated hypoxic perfusion with mitomycin C confers no benefit for patients with advanced pancreatic carcinoma].
Petrowsky H; Heinrich S; Staib-Sebler E; Gog C; Janshon G; Lorenz M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1351-3. PubMed ID: 9931879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
